Testosterone therapy and secondary erythrocytosis (2021)
Joshua White, Francis Petrella, and Jesse Ory
Secondary erythrocytosis is one of the most common adverse events associated with testosterone therapy (TT). Upon encountering this, clinicians will often either adjust TT dosing, stop...